Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Biomedica Biochimica Acta|January 1, 1991
The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicityA H Kaplan, R SwanstromProceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartmentsA H Kaplan, R SwanstromJournal of Virology|October 1, 1994
The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiencyA H Kaplan, M Manchester, R SwanstromJournal of Virology|September 1, 1996
Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replicationA H Kaplan, M Manchester, T Smith, et al.Antimicrobial Agents and Chemotherapy|December 1, 1994
Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNAA H Kaplan, P Krogstad, D J Kempf, et al.Nucleic Acids Research|March 11, 1995
Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1S F Chao, V L Chan, P Juranka, et al.Current Opinion in Biotechnology|August 1, 1994
Characterization of HIV-1 protease mutants: random, directed, selectedR SwanstromJournal of Virology|July 1, 1993
Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particlesA H Kaplan, J A Zack, M Knigge, et al.Journal of Virology|December 1, 1994
The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virionsS C Pettit, M D Moody, R S Wehbie, et al.Pharmacology & Therapeutics|May 9, 2000
Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistanceR Swanstrom, J EronaPageof 10